David Rodriguez
Clinical Genetics (M.D.) · Houston, TXNPI 1558521013
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (40.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Biomarin Pharmaceutical Inc. at 57.1% of the total.
Across 91 payments — averaging $303.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$16K
- Stryker$5K
- Ultragenyx Pharmaceutical Inc.$5K
- Modernatx, Inc.$2K
- BD$181
- Davol Inc.$138
- plus $148 from 2 others
Across 177 payments — averaging $6935.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ultragenyx Pharmaceutical Inc.$1.1M
- Modernatx, Inc.$122K
- Biomarin Pharmaceutical Inc.$45K
What the payments were for
- Consulting fees$3,48713%
- Speaking & faculty fees$11,07640%
- Travel & lodging$6,93125%
- Food & beverage$6,08522%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 32 | $15,760 |
| Stryker | 45 | $5,009 |
| Ultragenyx Pharmaceutical Inc. | 5 | $4,566 |
| Modernatx, Inc. | 5 | $1,808 |
| BD | 1 | $181 |
| Davol Inc. | 1 | $138 |
| Kyowa Kirin, Inc. | 1 | $130 |
| AstraZeneca | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$3,710
- INSIGNIA$439
- Channel Drain$181
- TRIATHLON$167
- ARISTA$138
- CRYSVITA$130
- VOXZOGO 1.2mg$129
How this compares
$27,610 in reported general payments places this provider in the 80th percentile of 37 clinical genetics (m.d.) providers in Texas.
Other clinical genetics (m.d.) in Houston
- Hope NorthrupHouston$180K
- Paul HillmanHouston$68K
- Brendan LeeHouston$28K
- Fernando ScagliaHouston$16K
- Claudia Soler-AlfonsoHouston$4K
- Andres Caceres SalgadoHouston$387
- Lilei ZhangHouston$193
- Laura FarachHouston$173
- Roni Zemet LazarHouston$172
- Lindsay BurrageHouston$23
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.